• Home
  • Sector News
    • Technology
    • Energy
    • Financial Services
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

What's Hot

1 Stealth Growth Stock to Buy and Hold Until 2030

June 4, 2023

1 Stock to Buy, 1 Stock to Sell This Week: Apple, Nio

June 4, 2023

Guggenheim Active Allocation Fund (GUG) announces monthly dividend of $0.12 per share

June 4, 2023
Telegram RSS
  • Government
  • Press Releases
  • Stock Market
  • Top Stories
  • Trading Insights
  • Trending
Telegram RSS
Virtus Junxit EquitiesVirtus Junxit Equities
  • Home
  • Sector News
    1. Technology
    2. Energy
    3. Financial Services
    4. View All

    Former Amazon Employee Reveals the Reason Behind Layoffs in Large Tech Companies

    June 3, 2023

    Bad Bunny’s Secret: Taking Breaks from Social Media Helps Him Feel Better

    June 3, 2023

    Vintage 2008 Video Shows Musk Presenting SpaceX’s Vision

    June 3, 2023

    Cathie Wood reduced her stake in Microsoft but increased holdings in PagerDuty and Ginkgo Bioworks

    June 3, 2023

    The Corn & Ethanol Report: Anticipating the Drought Monitor

    June 2, 2023

    Natural Gas Prices Increase as Risk Assets Rise

    June 2, 2023

    Crude Oil Prices Rise Prior to OPEC+ Meeting

    June 2, 2023

    Predicting Corn, Soybean, and Wheat Prices for June

    June 2, 2023

    ‘Fearless’ Taylor Swift Passes Madonna On Richest Self-Made Women List — Here’s Who Else The ‘All Too Well’ Singer Ranks Ahead Of – Live Nation Entertainment (NYSE:LYV)

    June 3, 2023

    Don’t let investment jargon intimidate you!

    June 3, 2023

    Grain Market Continues to be Volatile Ahead of Weekend – Corn, Soybeans, and Wheat Prices Being Closely Monitored

    June 2, 2023

    Chevron’s Attracts Investors Looking for Value and Short-Term Gains by Selling Out-of-the-Money Puts

    June 2, 2023

    1 Stealth Growth Stock to Buy and Hold Until 2030

    June 4, 2023

    1 Stock to Buy, 1 Stock to Sell This Week: Apple, Nio

    June 4, 2023

    Guggenheim Active Allocation Fund (GUG) announces monthly dividend of $0.12 per share

    June 4, 2023

    Better Buy: Peloton Interactive vs. Celsius Holdings

    June 4, 2023
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report
Get Access
Virtus Junxit EquitiesVirtus Junxit Equities
Home»Stock Market»Small Pharma’s Intellectual Property Portfolio Expands With Numerous Approved Patent Applications Globally – Small Pharma (OTC:DMTTF)
Stock Market

Small Pharma’s Intellectual Property Portfolio Expands With Numerous Approved Patent Applications Globally – Small Pharma (OTC:DMTTF)

JamesBy JamesMay 26, 2023Updated:May 26, 2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Small Pharma Inc., a U.K.-based company involved in developing short-acting psychedelics, has been dedicated to securing proprietary intellectual property (IP) across North America, Australasia, and Europe. CEO George Tziras stated that the company has made considerable progress in strengthening its IP position by creating multi-layered IP protection and optimizing each pipeline program’s commercial potential.

Small Pharma’s protection strategy includes discovering innovative drugs, their therapeutic compositions and medical uses, as well as synthesizing high-purity drug substances at scale.

Since February, Small Pharma has been granted five new patents, which include two covering the composition of matter for deuterated tryptamine homologs, one covering the novel synthesis of high-purity DMT and deuterated DMT analogs on a large scale, one for a unique injectable formulation of DMT-based compounds, and finally, one for therapeutic solid dosage forms of deuterated DMT analogs.

Additionally, three more patents covering the composition of matter of specific deuterated DMT analogs and deuterated DMT homologs that have medical use are expected to be granted by May 31.

Small Pharma has also received five notices of allowance on patents covering the composition of matter for a group of deuterated DMT homologs, medical usage, and therapeutic compositions of deuterated DMT homologs, and the novel synthesis of high-purity DMT and deuterated DMT analogs at scale.

Small Pharma’s psychedelic IP portfolio comprises 14 approved patents with 87 granted or pending patents. The drug development pipeline encompasses intravenous/intramuscular DMT compound SPL026, injectable deuterated DMT series SPL028, and oral tryptamine series SPL029.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleDown 84% From All-Time Highs, Should You Scoop Up Shares of C3.ai?
Next Article NetEase’s Strategy for Success in Games: Strong Growth in Cloud Music and Youdou Services
James

    Related Posts

    Page Industries (NSE:PAGEIND) Price Target Reduced by 7.67% to 39,341.08

    June 4, 2023By James0

    3M India (NSE:3MINDIA) Price Target Increased by 6.39% to 29,733.00

    June 4, 2023By James0

    DRAEGERWERK VZO O.N. (FWB:DRW3) Price Target Reduced by 6.64% to 53.33

    June 4, 2023By James0

    Leave A Reply Cancel Reply

    Our Picks

    Prime Minister’s Schedule for Sunday, June 4, 2023

    June 4, 2023

    Apareció Foundation’s Felix Magazine Launches New Issue Focusing on Wellness & Beauty, Featuring Sam Asghari

    June 4, 2023

    Bridging the Information Gap in Healthcare

    June 4, 2023

    SBI Launches Countrywide Search for Companies to Create Custom Board Games

    June 4, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    1 Stealth Growth Stock to Buy and Hold Until 2030

    Trending June 4, 2023

    The last decade has been frustrating for investors in General Motors (NYSE: GM). But the company is making smart investments for the future that set it up for significant gains for patient shareholders who are willing to hold the stock until 2030, despite recent rallies that never lasted. General Motors…

    Guggenheim Active Allocation Fund (GUG) announces monthly dividend of $0.12 per share

    June 4, 2023

    Better Buy: Peloton Interactive vs. Celsius Holdings

    June 4, 2023

    Academy Sports and Outdoors (ASO) announces regular quarterly dividend of $0.09 per share

    June 4, 2023
    FEATURED INSIGHTS​

    Virtus Junxit Equity Report: Loop Media, Inc. (AMEX: LPTV)

    May 31, 2023

    Virtus Junxit Equity Research: Hillstream BioPharma, Inc. (NASDAQ: HILS)

    May 18, 2023

    NeuroOne Medical NMTC Extreme Potential in Medical Tech

    May 14, 2023

    EZFill Holdings (EZFL) – An In-Depth Analysis of the Company’s Market Dynamics, Financials, and Upcoming Catalysts

    May 8, 2023

    Subscribe to stay informed!

    Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

    Telegram RSS
    • Home
    • Privacy Policy
    • Disclaimer
    • Virtus Report
    • Get Access
    © 2023 Virtus Junxit LLC

    Type above and press Enter to search. Press Esc to cancel.